Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

NCT05081180 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System Tumors

Interventions

DRUG: Avelumab
DRUG: Lenvatinib

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]